pravastatin has been researched along with Small Cell Lung Carcinoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Popat, S | 1 |
| Crosse, B; Cullen, M; Fife, KM; Hackshaw, A; Harden, S; Middleton, G; Muthukumar, D; Nash, S; Ngai, Y; Ottensmeier, CH; Schmid, P; Seckl, MJ; Taylor, P; Thompson, J | 1 |
| Brower, V | 1 |
1 trial(s) available for pravastatin and Small Cell Lung Carcinoma
| Article | Year |
|---|---|
Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Disease-Free Survival; Double-Blind Method; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Pravastatin; Response Evaluation Criteria in Solid Tumors; Small Cell Lung Carcinoma; Survival Rate | 2017 |
2 other study(ies) available for pravastatin and Small Cell Lung Carcinoma
| Article | Year |
|---|---|
Do Statins Improve Survival in Small-Cell Lung Cancer?
Topics: Double-Blind Method; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lung Neoplasms; Pravastatin; Small Cell Lung Carcinoma | 2017 |
Pravastatin has no advantage in small-cell lung cancer.
Topics: Antineoplastic Agents; Clinical Decision-Making; Clinical Trials, Phase III as Topic; Disease Progression; Disease-Free Survival; Humans; Lung Neoplasms; Patient Selection; Pravastatin; Randomized Controlled Trials as Topic; Small Cell Lung Carcinoma; Time Factors; Treatment Outcome | 2017 |